Radioimmunotherapy of patients with malignant brain tumors: patient-specific dosing of I-131-labeled anti-tenacin antibody to achieve 44 Gy boost dose to resection cavity margins

Journal Article

Full Text

Duke Authors

Cited Authors

  • Reardon, DA; Zalutsky, MR; Akabani, G; Coleman, RE; Friedman, AH; McLendon, RE; Friedman, HS; II, HJE; Kirkpatrick, J; Bigner, DD

Published Date

  • September 2006

Published In

Volume / Issue

  • 33 /

Start / End Page

  • S194 - S194

International Standard Serial Number (ISSN)

  • 1619-7070